Uncategorized Gevokizumab receives orphan drug designation by ModernMedecine • 2012/08/29 • 0 Comments Gevokizumab, a beta modulating antibody from XOMA Corp., has received FDA orphan drug designation for the treatment of several types of non-infectious uveitis. Full Story →